Article
RUNX1 as a Novel Molecular Target for Breast Cancer.
Clinical breast cancer - 1 Aug 2022
Ariffin Nur Syamimi
Abstract excerpt
RUNX1 has long known for its role in hematopoiesis until recently it is implicated in human breast cancer pathogenesis. This has drawn attention in research as elevated expression of RUNX1 has been observed in invasive breast cancer, and mutations of the RUNX1 gene and its binding partner CBFβ have been identified in luminal breast cancer patients, many of which have attributed to the development and progression...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
